biotech

Papillomavirus Vaccine May Reduce Vulval And Vaginal Cancers

Filed in archive Drugs, Vaccines and Therapeutics on May 20, 2007

Papillomavirus Vaccine May Reduce Vulval And Vaginal Cancers
According to a recent study, a quadrivalent Human Papillomavirus (HPV) vaccine is effective in preventing high-grade vulval and vaginal lesions that can lead to cancers in those areas.
Vaccine efficacy varied from 71% in women previously exposed to the human papillomaviruses to 100% in those not previously exposed. Additionally, a 49% reduction in all high-grade vulval and vaginal lesions, irrespective of casual HPV type, was seen in the intention-to-treat population of sexually active young women

The study has been published in this week's issue of The Lancet.

Soutce: Medical News Today

Permalink: Papillomavirus Vaccine May Reduce Vulval And Vaginal Cancers

Tags: HPV  cervical  cancer  papillomavirus  gardasil  vaginal+cancer  biotech  center+dubai 

Vote for Papillomavirus Vaccine May Reduce Vulval And Vaginal Cancers:

  • Currently 7.00/10
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
Rating: 7.00 out of 4 vote(s) cast.
 
Share It
RSSrss
Google google
Yahoo! yahoo
Addthis Subscribe using any feed reader!
Bloglines Bloglines
Most Popular   Best of   Biotech Hubs and Facilities   Biotech/Science Blogs   Corporate and Industrial News   Diagnostics, Methodologies and Instrumentation   Did you know   Drugs, Vaccines and Therapeutics   Energy, Environment and Ecology   Food and Agriculture   Gene Therapy   Genomics, Proteomics and Bioinformatics   Information About   Meetings and Other Events   Microbiology   Misc   Nanomedicine   Other Biotechnology News   Patents and Intellectual Property Rights   Quick introduction   Stem Cells